Artificial Blood: Global Markets to 2028

Sep 2023| BIO164B| BCC Publishing
Sample Report

Report Highlights

The global artificial blood market reached $23.9 million in 2022, should reach $26.1 million by 2023 and $40.5 million by 2028 with a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023-2028.

Report Includes

  • 41 tables
  • An overview of the global markets for artificial blood
  • Estimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of artificial blood market by product, application, and region
  • Examination of the key drivers and constraints that will shape the market and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and sub-segments
  • Coverage of recent advances, emerging technologies, and developments of the industry
  • Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
  • Company profiles of major players within the industry, including Hemarina, VirTechBio, and NuvOx Pharma

Report Scope

The scope of this study encompasses an investigation of the global market for artificial blood, focusing on various important aspects of the market, such as research and development, clinical trial outcomes, approval status, and the potential commercial demand for artificial blood products. The report includes a discussion of artificial oxygen carrier products. BCC Research analyzes each market segment and provides a forecast for six years. The current report analyzes the market's drivers, challenges, and opportunities. The report also covers market projections for 2028 and the market analysis for key market players. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also provides information on emerging technologies, the impact of COVID-19, product analysis, deals, and investment outlook.

Frequently Asked Questions (FAQs)

The artificial blood market is estimated to be $23.9 million in 2022 and is forecasted to grow at a CAGR of 9.2% to reach a value of $40.5 million in 2028.
The key factors contributing to the growth of the market include increasing demand for blood transfusions, risks and challenges associated with blood transfusions and shortage of blood supply.
In this report, the current market and the potential market is estimated.
Currently only one product is approved in the market, which is in Europe. However, in future, North America is expected to have the highest share followed by Europe and emerging markets. It is observed that majority of the startup companies are based in U.S and European regions and conducting trials in the base locations.
Key companies in the market include Hemarina, VirTechBio and NuvOx Pharma.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $23.9 million
Market size forecast $40.5 million
Growth rate CAGR of 9.2% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Source, Type
Regions covered North America, Europe, Emerging markets
Key Market Drivers
  • Increasing Demand for Blood Transfusions
  • Risks and Challenges Associated with Blood Transfusions
  • Shortage of Blood Supply
Companies studied

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
. Title/Chapter NamePagesPrice Member Price
Full Report: Artificial Blood: Global Markets to 2028120 $5,500 Free
Chapter- 1: Introduction4Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market Overview12$550Free
Chapter- 4: Market Dynamics8$367Free
Chapter- 5: Artificial Blood by Source10$458Free
Chapter- 6: Artificial Blood by Type16$733Free
Chapter- 7: Market Estimation8$367Free
Chapter- 8: Emerging Technologies and Developments5$229Free
Chapter- 9: Product Analysis36$1,650Free
Chapter- 10: Patent Analysis5$229Free
Chapter- 11: Competitive Intelligence3$138Free
Chapter- 12: Company Profiles10$458Free
Published - Apr-2018| Analyst - BCC Publishing| Code - BIO164A

Report Highlights

The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.

Report Includes

  • 144 tables
  • Country specific data and analysis for USA, Canada, Mexico, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, and South Africa
  • Identification of growth-driving factors influencing the artificial blood market, as well as opportunities, restraints, and technological developments
  • Profiles of leading companies in the market, including Alliance Pharmaceutical Corp., Baxter Healthcare Corp., Northfield Laboratories Inc., Sanguine Biosciences, and Therapure Biopharma Inc.
Artificial Blood: Global Markets to 2028

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.